Offer - Urjas Oil for just ₹ 1 X
Esiflo 250 Transhaler is a prescription medicine that is available as a Inhaler. Esiflo 250 Transhaler also has some secondary and off-label uses. These are listed below.
The optimal dosage of Esiflo 250 Transhaler is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Esiflo 250 Transhaler also has some side effects, the most common being Shortness of Breath, Throat Irritation, Nosebleed. Apart from the aforementioned side effects, Esiflo 250 Transhaler can also lead to other problems, which have been listed below. These side effects of Esiflo 250 Transhaler are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Esiflo 250 Transhaler's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Esiflo 250 Transhaler's effects on the liver, heart and kidney are discussed below in the Esiflo 250 Transhaler related warnings section.
Some other conditions that can be affected by Esiflo 250 Transhaler are listed in the contraindications section below.
Additionally, Esiflo 250 Transhaler may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Esiflo 250 Transhaler, it is important to know that it is safe while driving, and is habit-forming.
Esiflo 250 Transhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Esiflo 250 Transhaler safe for pregnant women?
Pregnant women may experience moderate side effects from Esiflo. It is best to stop taking Esiflo immediately and inform your doctor if you notice any discomfort.
Is the use of Esiflo 250 Transhaler safe during breastfeeding?
Esiflo may have very limited harmful effects for breastfeeding women.
What is the effect of Esiflo 250 Transhaler on the Kidneys?
Esiflo is not harmful for kidneys.
What is the effect of Esiflo 250 Transhaler on the Liver?
You may experience side effects on your liver after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Esiflo 250 Transhaler on the Heart?
You may experience side effects on your heart after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Esiflo 250 Transhaler unless your doctor advises you to do so -
Is this Esiflo 250 Transhaler habit forming or addictive?
No, you will not get addicted to Esiflo 250 Transhaler.
Interaction between Food and Esiflo 250 Transhaler
There isn't any research available on the side effects of taking Esiflo 250 Transhaler with food.
Interaction between Alcohol and Esiflo 250 Transhaler
No research has been done on this till date. Therefore, it is not known what the effect of taking Esiflo 250 Transhaler with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359